par Gevenois, Pierre-Alain 
;Sintzoff, Serge ;Stallenberg, Bernard ;Salmon, Isabelle ;Simon, Jacques ;Van Regemorter, Guy ;Struyven, Julien
Référence Journal belge de radiologie, 75, 1, page (5-10)
Publication Publié, 1992-02
;Sintzoff, Serge ;Stallenberg, Bernard ;Salmon, Isabelle ;Simon, Jacques ;Van Regemorter, Guy ;Struyven, Julien Référence Journal belge de radiologie, 75, 1, page (5-10)
Publication Publié, 1992-02
Article révisé par les pairs
| Résumé : | Fourteen patients with prostatic carcinoma, benign prostatic hyperplasia, or chronic granulomatous prostatitis underwent gadolinium-DOTA enhanced magnetic resonance imaging of the prostate. Gadolinium-DOTA was administered intravenously in a dosage of 0.1 mmol/kg body weight. All studies were performed on a superconductive 1.5-T system. As compared to noncontrast T1- and T2-weighted images, Gd-DOTA enhanced T1-weighted images were useful in distinguishing malignant tumor from granulomatous prostatitis in one case, but were uncontributive to the differentiation between carcinoma and benign prostatic hyperplasia. |
